Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inhibiteur neuraminidase")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 331

  • Page / 14
Export

Selection :

  • and

Neuraminidase inhibitors and their role in avian and pandemic influenzaCRUSAT, Martin; DE JONG, Menno D.Antiviral therapy (London). 2007, Vol 12, Num 4, pp 593-602, issn 1359-6535, 10 p., bArticle

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitorsMISHIN, Vasiliy P; HAYDEN, Frederick G; GUBAREVA, Larisa V et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4515-4520, issn 0066-4804, 6 p.Article

Neuraminidase Inhibitor Susceptibility Network position statement : antiviral resistance in influenza A/H5N1 virusesHAYDEN, Frederick; KLIMOV, Alexander; ZAMBON, Maria et al.Antiviral therapy (London). 2005, Vol 10, Num 8, pp 873-877, issn 1359-6535, 5 p.Article

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibilityYEN, Hui-Ling; HERLOCHER, Louise M; HOFFMANN, Erich et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4075-4084, issn 0066-4804, 10 p.Article

Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivoALYMOVA, Irina V; TAYLOR, Garry; TAKIMOTO, Toru et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1495-1502, issn 0066-4804, 8 p.Article

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitorsAI LEE CHEAM; BARR, Ian G; HAMPSON, Alan W et al.Antiviral research. 2004, Vol 63, Num 3, pp 177-181, issn 0166-3542, 5 p.Article

Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsGOVORKOVA, Elena A; FANG, Hong-Bin; MING TAN et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4855-4863, issn 0066-4804, 9 p.Article

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillanceKASHIWAGI, Seizaburo; YOSHIDA, Sanae; YAMAGUCHI, Hiroki et al.International journal of antimicrobial agents (Print). 2012, Vol 40, Num 5, pp 381-388, issn 0924-8579, 8 p.Article

Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsHATAKEYAMA, Shuji; SUGAYA, Norio; MITAMURA, Keiko et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 13, pp 1435-1442, issn 0098-7484, 8 p.Article

Resistant influenza a viruses in children treated with oseltamivir: descriptive study. CommentKISO, Maki; MITAMURA, Keiko; SAKAI-TAGAWA, Yuko et al.Lancet (British edition). 2004, Vol 364, Num 9436, pp 733-734, issn 0140-6736, 9 p.Article

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single AdministrationKUBO, Shuku; TOMOZAWA, Takanori; KAKUTA, Masayo et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 3, pp 1256-1264, issn 0066-4804, 9 p.Article

CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory TractKOYAMA, Kumiko; TAKAHASHI, Makoto; OITATE, Masataka et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 11, pp 4845-4851, issn 0066-4804, 7 p.Article

Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort studyNORDSTROM, Beth L; OH, Kelly; SACKS, Susan T et al.Antiviral therapy (London). 2004, Vol 9, Num 2, pp 187-195, issn 1359-6535, 9 p.Article

In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza VirusesHURT, Aeron C; HOLIEN, Jessica K; BARR, Ian G et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4433-4440, issn 0066-4804, 8 p.Article

Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removalBARRETT, Susan; MCKIMM-BRESCHKIN, Jennifer L.Antiviral research. 2014, Vol 108, pp 30-35, issn 0166-3542, 6 p.Article

Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy VolunteersISHIZUKA, Hitoshi; TOYAMA, Kaoru; YOSHIBA, Satoshi et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3873-3878, issn 0066-4804, 6 p.Article

Supratherapeutic oseltamivir levels during continuous dialysis: an expected riskESCHENAUER, Gregory A; LAM, Simon W.Intensive care medicine (Print). 2011, Vol 37, Num 2, issn 0342-4642, p. 371Article

Oseltamivir dose adjustment in an H1N1 patient requiring haemodialysisDOLLEY-HITZE, Thibault; VERDIER, Marie-Clémence; TRIBUT, Olivier et al.Intensive care medicine (Print). 2010, Vol 36, Num 9, pp 1618-1619, issn 0342-4642, 2 p.Article

Augmentation de la résistance à l'oseltamivir = More resistance to oseltamivir (Tamiflu)The Medical letter on drugs and therapeutics (Edition française). 2009, Vol 31, Num 4, pp 13-14, issn 0253-8512, 2 p.Article

Oséltamivir : saignements digestifs = Oseltamivir and digestive bleedingsLa Revue Prescrire. 2008, Vol 28, Num 293, pp 186-186, issn 0247-7750, 1 p.Article

Pharmacokinetics and Tolerability of Oseltamivir Combined with ProbenecidHOLODNIY, Mark; PENZAK, Scott R; DEYTON, Lawrence R et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 9, pp 3013-3021, issn 0066-4804, 9 p.Article

The threat of avian influenza H5N1 : 'do we have the tools for the job?'OXFORD, John; LAMBKIN-WILLIAMS, Robert; MANN, Alex et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 2, pp 71-74, issn 0956-3202, 4 p.Article

Pharmacokinetics of oseltamivir in young and very elderly subjectsABE, Masaichi; SMITH, James; URAE, Akinori et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 10, pp 1724-1730, issn 1060-0280, 7 p.Article

Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274YBURNHAM, Andrew J; BARANOVICH, Tatiana; MARATHE, Bindumadhav M et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2718-2730, issn 0066-4804, 13 p.Article

Oseltamivir: the real world dataFREEMANTLE, Nick; SHALLCROSS, L. J; KYTE, D et al.BMJ (Overseas and retired doctors ed.). 2014, Vol 348, Num 7953, pp 22-24, issn 1759-2151, 3 p.Article

  • Page / 14